Every trade that managers of Doseology Sciences Inc. disclose to SEDI is tracked on this page. The last twelve months, up to 18 October 2026, brought 5 filings signed by 1 insider.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of Doseology Sciences Inc. has been absent for the past year. Half of the filings or more reach the SEDI feed on the day of the trade. That lag is the time during which only the insider knows about the trade.
Across the 2,134 companies tracked on its exchange, the median is 12 filings; at 5 filings, this issuer sits below that mark.
Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
FY ended June 2025 · cache
5 of 5 declarations
Doseology Sciences Inc. is a company focused on developing dosing solutions for health products. It is listed on the XTSE market.